Sterling, yen dragged by fiscal and political worries
The pound and the yen came under strain on Wednesday, weighed down by renewed investor concerns over global fiscal health and political uncertainty in...
China has achieved a significant medical milestone, with its drug regulator announcing the approval of the country's first domestically developed 9-valent human papillomavirus (HPV) vaccine.
In a landmark development for public health, China's drug regulator has given the green light to the nation's first domestically developed 9-valent human papillomavirus (HPV) vaccine. The approval, announced Wednesday, marks a significant turning point, ending over a decade of foreign companies dominating the lucrative and critical HPV vaccine market within the country.
The newly approved vaccine is designed to target nine distinct strains of the human papillomavirus, making it only the second vaccine of its kind globally to offer such broad protection. HPV vaccines are widely recognised as crucial tools in preventing cervical cancer in women and genital cancers and warts in both men and women.
Human Papillomavirus (HPV) is a very common virus, primarily spread through close physical intimacy, with many types. While some types can cause warts, certain "high-risk" types are responsible for nearly all cases of cervical cancer, as well as other cancers in both men and women. Vaccination is a key method of prevention.
This approval represents a major stride in China's push for self-sufficiency in key pharmaceutical and healthcare sectors. It is expected to significantly bolster the country's vaccination efforts, potentially improving accessibility and affordability of this vital preventative measure for millions of Chinese citizens. The domestic production could also reduce reliance on international supply chains, ensuring more stable access to the vaccine.
Experts believe that the introduction of a homegrown 9-valent HPV vaccine will not only address a significant public health need but also stimulate further innovation within China's biopharmaceutical industry. This development is poised to have a profound impact on public health outcomes across China, offering robust protection against HPV-related diseases.
A powerful eruption at Japan’s Shinmoedake volcano sent an ash plume more than 3,000 metres high on Sunday morning, prompting safety warnings from authorities.
AnewZ has learned that India has once again blocked Azerbaijan’s application for full membership in the Shanghai Cooperation Organisation, while Pakistan’s recent decision to consider diplomatic relations with Armenia has been coordinated with Baku as part of Azerbaijan’s peace agenda.
The UK is gearing up for Exercise Pegasus 2025, its largest pandemic readiness test since COVID-19. Running from September to November, this full-scale simulation will challenge the country's response to a fast-moving respiratory outbreak.
A Polish Air Force pilot was killed on Thursday when an F-16 fighter jet crashed during a training flight ahead of the 2025 Radom International Air Show.
Zambia has formalised a strategic partnership with the International Vaccine Institute (IVI) to bolster domestic vaccine manufacturing capacity, the Zambia National Public Health Institute (ZNPHI) announced on Friday.
Four-time Tour de France winner Chris Froome was airlifted to hospital in Toulon after suffering a training crash which left him with broken ribs, a collapsed lung and a back fracture, his team Israel-Premier Tech said on Thursday (August 28).
Bulgaria reported outbreaks of highly pathogenic avian influenza on three farms in the southern part of the country, the World Organisation for Animal Health (WOAH) said on Monday, as Europe faces a seasonal upturn in the deadly disease.
Africa has unveiled a continental emergency preparedness and response plan to tackle cholera from September 2025 to February 2026.
Belarusian President Alexander Lukashenko said on Sunday he had undergone a full medical exam for the first time in his life and was found to be in good health.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment